Medical Insights from Industry

RSS
"Insights from Industry" is a dynamic series of interviews at the cutting edge of the medical industry. Every interviewee is a leader in their particular field and is handpicked to give an informative and accessible insight into their chosen field. These interviews are guaranteed to keep you in the know in a rapidly changing industry.
Alzheimer’s drug trial: an interview with Geoffrey Kempler, Chairman & CEO Prana Biotechnology

Alzheimer’s drug trial: an interview with Geoffrey Kempler, Chairman & CEO Prana Biotechnology

Companion diagnostics: an interview with Trevor Hawkins, SVP, Strategy, Innovation and Business Development for Siemens Healthcare Diagnostics

Companion diagnostics: an interview with Trevor Hawkins, SVP, Strategy, Innovation and Business Development for Siemens Healthcare Diagnostics

Combating antibiotic resistance: an interview with Ron Najafi, CEO NovaBay Pharmaceuticals

Combating antibiotic resistance: an interview with Ron Najafi, CEO NovaBay Pharmaceuticals

Interferon-free treatment for genotype-1b hepatitis C patients: an interview with Professor Wulf Boecher, Boehringer Ingelheim

Interferon-free treatment for genotype-1b hepatitis C patients: an interview with Professor Wulf Boecher, Boehringer Ingelheim

Artificial pancreas for type 1 diabetes patients: an interview with John Pritchard, Cambridge Consultants

Artificial pancreas for type 1 diabetes patients: an interview with John Pritchard, Cambridge Consultants

Fibromyalgia diagnosis: an interview with Dr. Bruce Gillis, CEO of EpicGenetics

Fibromyalgia diagnosis: an interview with Dr. Bruce Gillis, CEO of EpicGenetics

Stem cells in the aesthetic industry: an interview with Dr. Norma Kassardjian

Stem cells in the aesthetic industry: an interview with Dr. Norma Kassardjian

p53 restoration of function drug candidate: an interview with Dr. Wayne Danter, MD, FRCPC President and CEO of Critical Outcome Technologies

p53 restoration of function drug candidate: an interview with Dr. Wayne Danter, MD, FRCPC President and CEO of Critical Outcome Technologies

Saltwater-treatment for cystic fibrosis: an interview with Matthew Allen, Program Director at Cambridge Consultants

Saltwater-treatment for cystic fibrosis: an interview with Matthew Allen, Program Director at Cambridge Consultants

Endoscopic imaging: an interview with Len Farris, Vice President of Marketing, Americas, PENTAX Medical

Endoscopic imaging: an interview with Len Farris, Vice President of Marketing, Americas, PENTAX Medical

Orthopedic care: an interview with Dereesa Purtell Reid, CEO of Hoag Orthopedic Institute

Orthopedic care: an interview with Dereesa Purtell Reid, CEO of Hoag Orthopedic Institute

LDL cholesterol blood levels: an interview with Dr. Harvey Kaufman

LDL cholesterol blood levels: an interview with Dr. Harvey Kaufman

Chemotherapy devices: an interview with Damien Salauze, head of Curie-Cancer

Chemotherapy devices: an interview with Damien Salauze, head of Curie-Cancer

Solid formulations of the recombinant anthrax vaccine: an interview with Dr Mark Carnegie-Brown, CEO, Glide Pharma

Solid formulations of the recombinant anthrax vaccine: an interview with Dr Mark Carnegie-Brown, CEO, Glide Pharma

Smartphone solutions for clinical trials

Smartphone solutions for clinical trials

Mid-stream urine collection system: an interview with Giovanna Forte, Managing Director, Forte Medical

Mid-stream urine collection system: an interview with Giovanna Forte, Managing Director, Forte Medical

Patient compliance: an interview with Dr. Bassam Damaj, CEO of Innovus Pharma

Patient compliance: an interview with Dr. Bassam Damaj, CEO of Innovus Pharma

Ambulatory syringe pump training: an interview with Ruth Goodwin RGN, BSc Clinical Education Manager for CME Medical

Ambulatory syringe pump training: an interview with Ruth Goodwin RGN, BSc Clinical Education Manager for CME Medical

Peripheral neuropathic pain patch treatments: an interview with Anne Hodgkins, Astellas Pharma

Peripheral neuropathic pain patch treatments: an interview with Anne Hodgkins, Astellas Pharma

Kinase inhibitors: an interview with Jan Hoflack, CSO of Oncodesign

Kinase inhibitors: an interview with Jan Hoflack, CSO of Oncodesign

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.